Consano Bio spotlights advisory board backing C-1101 chronic sciatica program

The clinical-stage biotech said advisors including former U.S. Surgeon General Jerome Adams are helping shape clinical, regulatory and manufacturing strategy for its non-opioid LSR therapy.

Summary

verifying reliability

Terms & Concepts

No specialized terms available for this topic.